🇮🇳 India 🇺🇸 US
Healthcare SEO AI search (AIO) Local SEO & Google Business Profile Content marketing Performance marketing Google Ads Meta Ads Email & SMS marketing Reputation management Website design Branding YouTube & video Marketing consulting
Dental practices Pediatric practices Primary care Med spas Dermatology IVF & fertility Dallas (HQ) Houston New York All US cities and specialties
US healthcare marketing statistics Med spa consumer behavior report Dental patient experience report Google benchmarks: 9 specialties Free tools All US research US case studies
Software
Healthcare practices Pharma Medical devices
About Ichelon Consulting US How we work Santosh Reddy, Director Ravi Kumarraju, Partner & Director
Book a call with the US team Call +1 (724) 612-3694
We Do It Right. The right diagnosis. The right strategy. The right systems. Giving healthcare leaders the confidence to make better decisions, build stronger operations, and achieve sustainable growth. — Team Ichelon
State medical board series · Rhode Island · 2026

Rhode Island medical board advertising rules: the 5-37-5.1 guide

Rhode Island physician advertising is governed by R.I. Gen. Laws 5-37-5.1, which defines unprofessional conduct for physicians. Paragraph (2) covers "all advertising of medical business that is intended or has a tendency to deceive the public." Fee splitting for referrals and promoting products to exploit patients for financial gain are listed in the same section.

5-37-5.1(2)
Advertising intended or tending to deceive the public
5-37-5.1(12)
Dividing fees for bringing or referring a patient
5-37-5.1(6)
Promoting goods or services to exploit patients
Direct answer
  • The regulator is the Rhode Island Board of Medical Licensure and Discipline, within the Rhode Island Department of Health.
  • R.I. Gen. Laws 5-37-5.1(2): all advertising of medical business that is intended or has a tendency to deceive the public is unprofessional conduct. Intent is not required; a tendency to deceive is enough.
  • (6): promoting the sale of drugs, devices, appliances, goods or services in a way that exploits the patient for financial gain.
  • (12): dividing or agreeing to divide fees for bringing or referring a patient. (13): per-test payment arrangements with laboratories.
Not legal advice. This is marketing guidance written against the Rhode Island statutes and board rules cited below, checked against official sources in October 2026. Rules change and boards interpret them case by case. Consult a healthcare attorney licensed in Rhode Island and confirm any specific claim with the Rhode Island Board of Medical Licensure and Discipline before you publish.
How Ichelon Consulting US works
Custom-scoped retainers from $499/month, with a Business Associate Agreement signed for every US client.
Goals-Driven engagements · Performance-Linked Payout Models available. See how we work →
Ichelon Consulting US
  • Dallas, Texas LLC
  • 10-person US client team · Central Time (CST)
  • 25+ US healthcare clients
  • BAA signed with every client
  • HIPAA compliance training across client and delivery teams
  • Contracts and invoices in USD
How we work with US practices →
Trusted by US practices · case studies → 25+ US clients · 8 shown · TX · CA · VA · nationwide telehealth
Dr. Rajan Kohli
Owner, Lakewood Primary Care & Wellness · North Dallas, TX
Client video · Practice website build
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
Dr. Rajan Kohli Owner, Lakewood Primary Care & Wellness · North Dallas, TX
Regulator map

Which boards regulate Rhode Island healthcare advertising

The Rhode Island Board of Medical Licensure and Discipline licenses and disciplines physicians under R.I. Gen. Laws Chapter 5-37, and sits within the Rhode Island Department of Health. Unprofessional conduct is defined in 5-37-5.1. Dentists are licensed by the Rhode Island Board of Dentistry, also within the Department of Health.

Citation: R.I. Gen. Laws 5-37-5.1(2), (6), (12), (13). Text confirmed through a published copy because the Rhode Island Legislature site blocked automated access.
The core rule

R.I. Gen. Laws 5-37-5.1: the grounds that reach marketing

(2) Advertising that tends to deceive

"All advertising of medical business that is intended or has a tendency to deceive the public." Two features matter. First, "all advertising" means every channel. Second, "or has a tendency to deceive" means a practice can be found in violation without intending to mislead anyone. Overall impression, omitted conditions and selective results count.

(6) Exploiting patients through product promotion

Promoting the sale of drugs, devices, appliances, or goods or services provided for a patient in a way that exploits the patient for financial gain. Retail skincare, supplements, membership plans and add-on packages sold in the practice need a fair, non-pressured presentation.

(12) and (13) Referral money

Dividing fees, or agreeing to split or divide fees received for professional services, with any person for bringing or referring a patient is listed. So is agreeing to accept payments from clinical or bioanalytical laboratories for individual tests or test series.

Where Rhode Island practices slip. A practice pays a marketing partner a percentage of collections from patients the partner "brings in", and its email campaign pushes a supplement bundle to post-procedure patients with a countdown timer. That raises questions under (12) and (6), on top of (2) if the email overstates results.
Citation: R.I. Gen. Laws 5-37-5.1.
Working table

Allowed, prohibited, needs disclosure: the Rhode Island working table

How we apply R.I. Gen. Laws 5-37-5.1 on Rhode Island pre-publication reviews.

Creative elementStatusPractical rule and basis
Superlatives and comparisonsNeeds substantiationAnything with a tendency to deceive is covered (5-37-5.1(2)).
Outcome guaranteesProhibited in practiceA guarantee of a clinical result tends to deceive (2).
Revenue-share marketing dealsHigh riskDividing fees for bringing or referring a patient (5-37-5.1(12)). Get legal review.
In-office retail and upsellsNeeds careNo promotion that exploits patients for financial gain (5-37-5.1(6)).
Testimonials and before-and-after imagesAllowed with careMust not tend to deceive; typical results or clear disclosure; HIPAA authorization.
Board certificationAllowed if accurateName the board; inaccurate credentials tend to deceive.
Price promotionsAllowed with careAll conditions and expiry on the same screen as the price.
State-specific twists

What is different about Rhode Island

"Tendency to deceive" lowers the bar

Because intent is not required, a Rhode Island review should look at how a typical patient would read the ad, including images, small print and what is left out.

Retail and membership marketing

Paragraph (6) makes product and package promotion a licensing issue when it exploits patients. Keep sales messages factual, avoid pressure tactics aimed at patients during or right after care, and make pricing clear.

Lab arrangements

Paragraph (13) is unusual: it names per-test payments from laboratories. Practices marketing in-house testing or lab panels should check how lab relationships are paid.

Federal layer

How federal rules layer on top of Rhode Island law

Rhode Island board rules sit on top of a federal floor that applies to every US practice. In short:

  • FTC Act and the Endorsement Guides (16 CFR Part 255). Claims need a reasonable basis before they run. Reviews, testimonials and influencer posts must reflect real experience, and any material connection (payment, free treatment, staff or family ties) must be disclosed clearly. If results shown are not what patients generally get, say what they can generally expect.
  • FTC rule on consumer reviews and testimonials (16 CFR Part 465, effective October 21, 2024). Bans fake or AI-invented reviews, buying positive reviews, undisclosed insider reviews and review suppression, with civil penalties available per violation.
  • HIPAA marketing rule (45 CFR 164.501 and 164.508(a)(3)). Using a patient's protected health information in marketing (a named testimonial, a before-and-after photo, a case story) generally needs the patient's signed written authorization. Replying to an online review in a way that confirms someone is a patient can be an impermissible disclosure. Tracking pixels on pages that collect health information need a careful look too. See our HIPAA-compliant healthcare marketing guide.
  • TCPA (47 U.S.C. 227; 47 CFR 64.1200). Marketing texts and autodialed or prerecorded calls to mobile phones need prior express written consent. Keep the consent record and honor opt-outs.
  • CAN-SPAM. Marketing email needs an accurate sender, a non-deceptive subject line, a physical address and a working unsubscribe.

Platform policies (Google Ads healthcare and medicines policy, Meta's health and wellness ad rules) are a further layer. They can reject an ad that is lawful in Rhode Island, so plan creative to clear all three: state rule, federal rule, platform rule.

Practical checklist

Rhode Island compliance checklist for website, ads, social and reviews

Website and provider pages

Review every page for overall impression, not just literal accuracy. Product pages give clear prices and avoid pressure. Credentials are accurate and name the certifying board.

Paid search and paid social

Remove guarantees and unsupported comparisons. Check that no marketing contract is priced as a share of fees from referred patients.

Organic social and influencers

Disclose every material connection on the post itself (#ad or "paid partnership", plus free treatment or discounts). Get a HIPAA authorization before posting any patient image or story. Keep result claims to what patients generally achieve.

Reviews and reputation

Ask every patient the same way, never pay or discount for a review, and never gate or suppress negative ones. Reply without confirming that the reviewer is a patient or discussing their care; move details offline.

Retail and upsell review

Review in-office product and package promotions against 5-37-5.1(6) before launch, especially post-procedure emails and texts.

Substantiation file

For every factual claim (years in practice, procedure counts, certifications, "first" or "only" claims), keep a dated record of the evidence. Review the file when credentials, staff or services change.

FAQ

Rhode Island medical advertising: common questions

What Rhode Island law covers physician advertising?

R.I. Gen. Laws 5-37-5.1(2), which defines all advertising of medical business that is intended or has a tendency to deceive the public as unprofessional conduct.

Does an ad have to be intentionally deceptive to violate Rhode Island law?

No. The statute covers advertising that is intended to deceive or that has a tendency to deceive the public.

Can a Rhode Island practice share revenue with a marketing partner?

Be careful. Dividing fees with anyone for bringing or referring a patient is unprofessional conduct under 5-37-5.1(12). Get legal advice before any revenue-share or per-patient arrangement.

Are in-office product sales regulated?

Promoting drugs, devices, appliances, goods or services in a way that exploits the patient for financial gain is listed in 5-37-5.1(6).

Which board regulates Rhode Island physicians?

The Rhode Island Board of Medical Licensure and Discipline, within the Rhode Island Department of Health.

Sources

Sources

Official Rhode Island sources first, then federal. Where an official site blocked automated access, we confirmed the text through a published copy of the same section and say so below.

  1. R.I. Gen. Laws 5-37-5.1 (Rhode Island General Assembly, official)
  2. R.I. Gen. Laws 5-37-5.1, published copy used to confirm paragraph text (FindLaw)
  3. Rhode Island Department of Health, professional licensing
  4. FTC Guides Concerning the Use of Endorsements and Testimonials in Advertising, 16 CFR Part 255 (eCFR)
  5. FTC Trade Regulation Rule on the Use of Consumer Reviews and Testimonials, 16 CFR Part 465 (eCFR)
  6. Final rule notice, 89 Fed. Reg. (August 22, 2024), effective October 21, 2024 (GovInfo)
  7. HIPAA Privacy Rule, uses and disclosures requiring authorization, 45 CFR 164.508 (eCFR)
  8. HIPAA Privacy Rule definitions including "marketing", 45 CFR 164.501 (eCFR)
  9. TCPA implementing rules, 47 CFR 64.1200 (eCFR)
Marketing guidance, not legal advice. This page reflects how the Ichelon Consulting US team reviews Rhode Island healthcare marketing. It is not legal advice and does not create an attorney-client relationship. Confirm specific claims with a Rhode Island-licensed healthcare attorney or with the Rhode Island Board of Medical Licensure and Discipline. Questions about this page: +1 (724) 612-3694.

Get your Rhode Island marketing checked before it runs

Book a call with the Ichelon Consulting US team in Dallas (Central Time). We review your website, ads and review responses against the Rhode Island rules above and the federal layer, then fix what needs fixing. Every US client signs a BAA with us; our client-facing team holds HIPAA compliance training certificates. Retainers are custom-scoped, from $499/month.

Chat with Sr. Leadership
🎯 Goals-Driven engagements · Performance-Linked Payout Models
Chat with Sr. Leadership